Low-fucosylation tumours demonstrated mesenchymal phenotypes, <i>TP53</i> mutations, chromosomal instability, comprehensive multi-family RTK signalling, immune-excluded microenvironments, and poor outcomes. This evidence concerns the gene TP53 and neoplasm.